Skip to content

Phase 2a Study of TS-133 in Alopecia

Phase 2a Study of TS-133 in Alopecia

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223348
Enrollment
Unknown
Registered
2016-10-17
Start date
2016-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia

Interventions

investigational material(s) Generic name etc : TS-133 INN of investigational material : Therapeutic category code : 267 Hair remedies (including hair growth stimulants, depilatorys, dyes and tonics)

Sponsors

Taisho Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: - Alopecia - Outpatients etc.

Exclusion criteria

Exclusion criteria: - Patients with scars of the scalp or any other disease of the scalp or hair - Having critical hepatic disease, renal disease, heart disease and hematologic disease etc.

Design outcomes

Primary

MeasureTime frame
hair count assessment

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026